home arrow home arrow 10 drugmakers team on testing

Login Form






Lost Password?
No account yet? Register
DIGITAL EDITION
10 drugmakers team on testing PDF Print E-mail
Written by LINDA A. JOHNSON   
Monday, 22 October 2012

ambulance_logo.jpgTRENTON, N.J. — Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.

Ten top U.S. and European drugmakers said Wednesday that they have started a nonprofit organization, called TransCelerate BioPharma, to collaborate on the problem.

STRATEGIES

Research productivity across the industry has been declining while costs have been rising over the past few decades. About 5,000 to 10,000 potential drugs fail for every one approved, although all but about five of those compounds are scrapped by the time costly tests in people begin.

Including all the failed drugs, the cost of getting one approved has risen from about $140 million in the 1970s to more than $1.2 billion, according to the
industry group Pharmaceutical Research and Manufacturers of America. That's partly because the process from finding a compound to getting it approved by regulators takes 10 to 15 years.

TransCelerate will aim to shorten that time and reduce costs along the way, initially by developing strategies to make it easier and quicker to set up and run clinical tests of experimental drugs.

That will include developing standard methodology for collecting data from patient tests and ensuring that study participants are protected, as well as setting standards for qualifying clinic sites and investigators to work on studies.

FASTER, BETTER.

Another goal is to increase the number of researchers at hospitals and universities qualified to conduct trials, because that will give more patients the chance to participate in them.

“It will enable everybody to develop new drugs faster and better,” said the group's acting CEO, Garry Neil. “If this helps to reduce costs, then maybe we can investigate more drugs.”

That's clearly needed, as the number of innovative drugs approved each year has been declining.

Comments (0)Add Comment

Write comment
This content has been locked. You can no longer post any comments.

busy
Last Updated ( Tuesday, 23 October 2012 )
 
< Prev   Next >
 

LATEST NEWS

AP Latest News Video




Alcohol Awareness Month


Polls

Which Governor Provided The Most Opportunities for Black Businesses?
 
 
Bill creates unfunded mandate, Islamic group saysBill creates unfunded mandate, Islamic group says
TALLAHASSEE, Fla. (AP) - A Muslim activist group says a bill that would require the state's school districts to rev...
Read more...
‘Rio 2’ dazzling but overloaded ‘Rio 2’ dazzling but overloaded
A vivid and delightful animated spectacle, Rio 2 is chock-full of colorful 3-D wonder and jubilant musical numbers set ...
Read more...
FTC:  Jerk.com Scammed ConsumersFTC: Jerk.com Scammed Consumers
WASHINGTON (AP) — The Federal Trade Commission says the operators of a website called Jerk.com are the ones behaving badl...
Read more...
Google Glass, good for cooking, needs InternetGoogle Glass, good for cooking, needs Internet
NEW YORK — Google Glass is like a fickle friend. Surprises await, such as the time it took a photo of my ceiling while...
Read more...

Wellness News



The most influential African American weekly newspaper in South Florida

Beatty Media LLC